Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 180, Issue 2, Pages 296-298Publisher
WILEY
DOI: 10.1111/bjh.14314
Keywords
myeloma; myeloma therapy; cancer; risk factors
Categories
Funding
- Array BioPharma
- Novartis
- Millennium/Takeda
- Celgene
- Amgen-Onyx
- Janssen